Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

High Dose Cyclophosphamide Followed by Glatiramer Acetate in the Treatment of Relapsing Remitting Multiple Sclerosis

Phase 2

Withdrawn

Conditions: Relapsing Remitting Multiple Sclerosis

Interventions: Drug: Cyclophosphamide/Glatiramer acetate

First Posted Date: 2009-07-15

Last Posted Date: 2018-09-26

Lead Sponsor: Johns Hopkins University

Registration Number: NCT00939549

Locations: 🇺🇸
Johns Hopkins Hospital Multiple Sclerosis Center, Baltimore, Maryland, United States

SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy

Phase 1

Terminated

Conditions: Diabetic Macular Edema (DME)
Pars Plana Vitrectomy

Interventions: Drug: SAR 1118 0.1%
Drug: SAR 1118 1.0%
Drug: SAR 1118 5.0%

First Posted Date: 2009-07-10

Last Posted Date: 2017-05-10

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT00936520

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Acupressure and Acupuncture as an Intervention With Children With Autism II

Not Applicable

Completed

Conditions: Autism Spectrum Disorder

Interventions: Device: Acupressure and Acupuncture

First Posted Date: 2009-07-09

Last Posted Date: 2017-04-18

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 10

Registration Number: NCT00935701

Locations: 🇺🇸
Kennedy Krieger Institute, Baltimore, Maryland, United States

Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography

Phase 3

Completed

Conditions: Coronary Artery Disease
Vascular Diseases
Arterial Occlusive Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia
Arteriosclerosis
Ischemia

Interventions: Procedure: 320 Volume Detector Computed Tomography

First Posted Date: 2009-07-08

Last Posted Date: 2018-09-05

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 444

Registration Number: NCT00934037

Locations: 🇸🇬
Mount Elizabeth Hospital, Singapore, Singapore
🇯🇵
St. Luke's International Hospital, Tokyo, Japan
🇨🇦
Toronto General Hospital, Toronto, Canada

and more 13 locations

Culturally Sensitive Behavioral Interventions to Enhance Living Kidney Donation / Living Kidney Transplantation

Not Applicable

Completed

Conditions: Chronic Kidney Disease

Interventions: Behavioral: TALK Standard
Behavioral: Usual Care
Behavioral: TALK PLUS

First Posted Date: 2009-07-03

Last Posted Date: 2017-12-11

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 145

Registration Number: NCT00932334

Evaluating the Effects of a Diet and Exercise Program in People With Type 2 Diabetes or Prediabetes: (The SHAPE3 Study)

Phase 4

Completed

Conditions: Overweight
Obesity
Type 2 Diabetes
Prediabetes

Interventions: Behavioral: Weight loss diet
Behavioral: Weight loss diet plus exercise

First Posted Date: 2009-06-25

Last Posted Date: 2013-04-04

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 77

Registration Number: NCT00928005

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

PRIDE: Preventing Respiratory Illnesses During Childhood Study

Not Applicable

Completed

Conditions: Tobacco Smoke Pollution

Interventions: Behavioral: Educational Program for ETS Reduction
Behavioral: Motivational Interviewing Intervention for ETS Reduction

First Posted Date: 2009-06-24

Last Posted Date: 2017-08-24

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 350

Registration Number: NCT00927264

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Study of Ocular Penetration of Topically Administered Fluoroquinolones

Phase 4

Completed

Conditions: Cataract Extraction

Interventions: Drug: Besifloxacin 0.6% ophthalmic suspension
Drug: Moxifloxacin 0.5% ophthalmic solution

First Posted Date: 2009-06-19

Last Posted Date: 2017-10-24

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 50

Registration Number: NCT00924729

Locations: 🇺🇸
The Wilmer Eye Institute at Johns Hopkins University, Baltimore, Maryland, United States

Sodium Nitrite in Acute Myocardial Infarction

Phase 2

Completed

Conditions: Acute Myocardial Infarction

Interventions: Drug: Sodium Nitrite

First Posted Date: 2009-06-18

Last Posted Date: 2018-05-14

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT00924118

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
University of Massachusetts Medical School, Worcester, Massachusetts, United States

Study in PRE-manifest Huntington's Disease of Coenzyme Q10 (UbiquinonE) Leading to Preventive Trials (PREQUEL)

Phase 2

Completed

Conditions: Huntington's Disease

Interventions: Drug: CoQ10

First Posted Date: 2009-06-15

Last Posted Date: 2017-09-25

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 90

Registration Number: NCT00920699

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
University of California Davis, Sacramento, California, United States
🇺🇸
Colorado Neurological Institute, Englewood, Colorado, United States

and more 10 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy